Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT02858362 · TERMINATED
Trial details
- NCT number
- NCT02858362
- Sponsor
- Summit Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-04-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.